Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Collaborative European study finds immune cells which protect against heart disease

06.02.2006


Atherosclerosis, an accumulation of fat and inflammation in arteries, causes myocardial infarction and stroke, two deadly complications. The risk factors for atherosclerosis are well known and include hypercholesterolemia, smoking, diabetes and high blood pressure. Protective factors may also be important in atherosclerosis but are poorly understood. A new study published in this month´s issue of Nature Medicine presents the discovery of such a protective mechanism, which could be of great importance for future therapy.

A collaborative effort organized within the European Vascular Genomics Network (EVGN) has identified a subpopulation of T lymphocytes (called natural T regulatory cells, or Treg), which inhibit the formation of atherosclerotic plaques. Drs. Alain Tedgui and Ziad Mallat of INSERM U689 in Paris and Dr. Goran Hansson of Karolinska Institute´s Center for Molecular Medicine in Stockholm led two of the research teams in the study.

The senior author of the study Dr. Ziad Mallat explains the theory behind the study: “We postulated that in atherosclerosis there is an imbalance between regulatory and pathogenic immunity, and that such a disequilibrium promotes both plaque development and plaque inflammation”.

“We tested our hypothesis in a mouse model of the human disease, explains Mallat. “If these Treg were absent, the animals developed bigger atherosclerotic lesions. But when we injected the Treg cells they could turn off the atherosclerotic process”.



Further support for a controlling role of Treg in atherosclerosis came when the scientists inactivated these cells by injecting antibodies that blocked their activity. “We observed – says Dr. Alain Tedgui, President of EVGN and head of the Paris group – that antibody-treated mice - where the Treg were sort of handcuffed and hence unable to do their job - developed bigger lesions than their control counterparts.”

The scientists went one step further and identified a key molecule which is made by Treg and inhibits atherosclerosis. “Gene technology made it possible for us to turn off a signalling molecule called TGF-beta”, says Dr Goran Hansson. “The Treg cells then lost their protective activity. This tells us that TGF-beta is an important tool by which Treg protect against atherosclerosis.”

Dr Alain Tedgui now sees interesting opportunities for cardiovascular medicine: “Early that it might be, it is reasonable to consider novel kinds of therapies based on regulatory immune cells”.

EVGN is a network of excellence funded through the European Union Research Programme.

Francesca Noceti | alfa
Further information:
http://www.evgnvascularscience.org
http://www.ifom-ieo-campus.it

More articles from Life Sciences:

nachricht 'Y' a protein unicorn might matter in glaucoma
23.10.2017 | Georgia Institute of Technology

nachricht Microfluidics probe 'cholesterol' of the oil industry
23.10.2017 | Rice University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>